(1S)-1,5-Anhydro-1-[3-(3,4-dihydroxyphenyl)-7-hydroxy-4-oxo-4H-chromen-8-yl]-D-glucitol(CAS: 117060-54-5)

This compound is subject to the GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for classification and labeling. In the EU, it is regulated under REACH (Registration, Evaluation, Authorization and Restriction of Chemicals). FDA and EPA have specific regulations for pharmaceutical and environmental safety, respectively. Detailed safety data sheets (SDS) must be prepared and available for handling and transport.

Syntheses of this compound can often utilize precursors such as 7-hydroxy-4-methylcoumarin and D-glucitol. Common alternatives include other chromone derivatives and their glycosides. Isomeric forms or analogs like 7-hydroxy-4-hydroxycoumarin can also be used as substitutes depending on the intended application.

The market for this compound is growing due to its use in pharmaceuticals and natural product research. There is increasing interest in its potential as an anti-inflammatory and anti-cancer agent. Research trends focus on understanding its biological activity and developing more efficient synthetic methods.

Waste containing this compound should be collected in appropriate containers and stored under controlled conditions. Upon disposal, incineration is recommended due to its chemical stability and potential for degradation. Environmental precautions include ensuring no contamination of soil or water, and adhering to local waste management regulations. Proper waste disposal services should be utilized to ensure compliance with environmental laws.